Global H1N1 Vaccines Market Research Report 2022

Global H1N1 Vaccines Market Research Report 2022

Table of Contents
1 H1N1 Vaccines Market Overview
1.1 Product Overview and Scope of H1N1 Vaccines
1.2 H1N1 Vaccines Segment by Type
1.2.1 Global H1N1 Vaccines Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Intramuscular Vaccines
1.2.3 Intranasal Vaccines
1.2.4 Intradermal Vaccines
1.3 H1N1 Vaccines Segment by Application
1.3.1 Global H1N1 Vaccines Sales Comparison by Application: (2022-2028)
1.3.2 Influenza
1.3.3 Meningococcal
1.3.4 Cervical Cancer
1.3.5 Pneumococcal
1.3.6 Hepatitis
1.3.7 Measles
1.3.8 Mumps
1.3.9 Rubella
1.3.10 Others
1.4 Global H1N1 Vaccines Market Size Estimates and Forecasts
1.4.1 Global H1N1 Vaccines Revenue 2017-2028
1.4.2 Global H1N1 Vaccines Sales 2017-2028
1.4.3 H1N1 Vaccines Market Size by Region: 2017 Versus 2021 Versus 2028
2 H1N1 Vaccines Market Competition by Manufacturers
2.1 Global H1N1 Vaccines Sales Market Share by Manufacturers (2017-2022)
2.2 Global H1N1 Vaccines Revenue Market Share by Manufacturers (2017-2022)
2.3 Global H1N1 Vaccines Average Price by Manufacturers (2017-2022)
2.4 Manufacturers H1N1 Vaccines Manufacturing Sites, Area Served, Product Type
2.5 H1N1 Vaccines Market Competitive Situation and Trends
2.5.1 H1N1 Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest H1N1 Vaccines Players Market Share by Revenue
2.5.3 Global H1N1 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 H1N1 Vaccines Retrospective Market Scenario by Region
3.1 Global H1N1 Vaccines Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global H1N1 Vaccines Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America H1N1 Vaccines Market Facts & Figures by Country
3.3.1 North America H1N1 Vaccines Sales by Country
3.3.2 North America H1N1 Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe H1N1 Vaccines Market Facts & Figures by Country
3.4.1 Europe H1N1 Vaccines Sales by Country
3.4.2 Europe H1N1 Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific H1N1 Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific H1N1 Vaccines Sales by Region
3.5.2 Asia Pacific H1N1 Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America H1N1 Vaccines Market Facts & Figures by Country
3.6.1 Latin America H1N1 Vaccines Sales by Country
3.6.2 Latin America H1N1 Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa H1N1 Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa H1N1 Vaccines Sales by Country
3.7.2 Middle East and Africa H1N1 Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global H1N1 Vaccines Historic Market Analysis by Type
4.1 Global H1N1 Vaccines Sales Market Share by Type (2017-2022)
4.2 Global H1N1 Vaccines Revenue Market Share by Type (2017-2022)
4.3 Global H1N1 Vaccines Price by Type (2017-2022)
5 Global H1N1 Vaccines Historic Market Analysis by Application
5.1 Global H1N1 Vaccines Sales Market Share by Application (2017-2022)
5.2 Global H1N1 Vaccines Revenue Market Share by Application (2017-2022)
5.3 Global H1N1 Vaccines Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott H1N1 Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Abbott H1N1 Vaccines Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Baxter International
6.2.1 Baxter International Corporation Information
6.2.2 Baxter International Description and Business Overview
6.2.3 Baxter International H1N1 Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Baxter International H1N1 Vaccines Product Portfolio
6.2.5 Baxter International Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi H1N1 Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Sanofi H1N1 Vaccines Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK H1N1 Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.4.4 GSK H1N1 Vaccines Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer H1N1 Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Pfizer H1N1 Vaccines Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Mitsubishi Tanabe Pharma
6.6.1 Mitsubishi Tanabe Pharma Corporation Information
6.6.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.6.3 Mitsubishi Tanabe Pharma H1N1 Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Mitsubishi Tanabe Pharma H1N1 Vaccines Product Portfolio
6.6.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.7 Hualan Biological Engineering
6.6.1 Hualan Biological Engineering Corporation Information
6.6.2 Hualan Biological Engineering Description and Business Overview
6.6.3 Hualan Biological Engineering H1N1 Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Hualan Biological Engineering H1N1 Vaccines Product Portfolio
6.7.5 Hualan Biological Engineering Recent Developments/Updates
6.8 Cipla
6.8.1 Cipla Corporation Information
6.8.2 Cipla Description and Business Overview
6.8.3 Cipla H1N1 Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Cipla H1N1 Vaccines Product Portfolio
6.8.5 Cipla Recent Developments/Updates
6.9 Merck
6.9.1 Merck Corporation Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck H1N1 Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Merck H1N1 Vaccines Product Portfolio
6.9.5 Merck Recent Developments/Updates
6.10 Sinovac Biotech
6.10.1 Sinovac Biotech Corporation Information
6.10.2 Sinovac Biotech Description and Business Overview
6.10.3 Sinovac Biotech H1N1 Vaccines Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Sinovac Biotech H1N1 Vaccines Product Portfolio
6.10.5 Sinovac Biotech Recent Developments/Updates
7 H1N1 Vaccines Manufacturing Cost Analysis
7.1 H1N1 Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of H1N1 Vaccines
7.4 H1N1 Vaccines Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 H1N1 Vaccines Distributors List
8.3 H1N1 Vaccines Customers
9 H1N1 Vaccines Market Dynamics
9.1 H1N1 Vaccines Industry Trends
9.2 H1N1 Vaccines Market Drivers
9.3 H1N1 Vaccines Market Challenges
9.4 H1N1 Vaccines Market Restraints
10 Global Market Forecast
10.1 H1N1 Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of H1N1 Vaccines by Type (2023-2028)
10.1.2 Global Forecasted Revenue of H1N1 Vaccines by Type (2023-2028)
10.2 H1N1 Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of H1N1 Vaccines by Application (2023-2028)
10.2.2 Global Forecasted Revenue of H1N1 Vaccines by Application (2023-2028)
10.3 H1N1 Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of H1N1 Vaccines by Region (2023-2028)
10.3.2 Global Forecasted Revenue of H1N1 Vaccines by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global H1N1 Vaccines Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global H1N1 Vaccines Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global H1N1 Vaccines Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global H1N1 Vaccines Market Competitive Situation by Manufacturers in 2021
Table 5. Global H1N1 Vaccines Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global H1N1 Vaccines Sales Market Share by Manufacturers (2017-2022)
Table 7. Global H1N1 Vaccines Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global H1N1 Vaccines Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market H1N1 Vaccines Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers H1N1 Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers H1N1 Vaccines Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global H1N1 Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in H1N1 Vaccines as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global H1N1 Vaccines Sales by Region (2017-2022) & (K Units)
Table 16. Global H1N1 Vaccines Sales Market Share by Region (2017-2022)
Table 17. Global H1N1 Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global H1N1 Vaccines Revenue Market Share by Region (2017-2022)
Table 19. North America H1N1 Vaccines Sales by Country (2017-2022) & (K Units)
Table 20. North America H1N1 Vaccines Sales Market Share by Country (2017-2022)
Table 21. North America H1N1 Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America H1N1 Vaccines Revenue Market Share by Country (2017-2022)
Table 23. Europe H1N1 Vaccines Sales by Country (2017-2022) & (K Units)
Table 24. Europe H1N1 Vaccines Sales Market Share by Country (2017-2022)
Table 25. Europe H1N1 Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe H1N1 Vaccines Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific H1N1 Vaccines Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific H1N1 Vaccines Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific H1N1 Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific H1N1 Vaccines Revenue Market Share by Region (2017-2022)
Table 31. Latin America H1N1 Vaccines Sales by Country (2017-2022) & (K Units)
Table 32. Latin America H1N1 Vaccines Sales Market Share by Country (2017-2022)
Table 33. Latin America H1N1 Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America H1N1 Vaccines Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa H1N1 Vaccines Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa H1N1 Vaccines Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa H1N1 Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa H1N1 Vaccines Revenue Market Share by Country (2017-2022)
Table 39. Global H1N1 Vaccines Sales by Type (2017-2022) & (K Units)
Table 40. Global H1N1 Vaccines Sales Market Share by Type (2017-2022)
Table 41. Global H1N1 Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global H1N1 Vaccines Revenue Share by Type (2017-2022)
Table 43. Global H1N1 Vaccines Price by Type (2017-2022) & (USD/Unit)
Table 44. Global H1N1 Vaccines Sales (K Units) by Application (2017-2022)
Table 45. Global H1N1 Vaccines Sales Market Share by Application (2017-2022)
Table 46. Global H1N1 Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global H1N1 Vaccines Revenue Share by Application (2017-2022)
Table 48. Global H1N1 Vaccines Price by Application (2017-2022) & (USD/Unit)
Table 49. Abbott Corporation Information
Table 50. Abbott Description and Business Overview
Table 51. Abbott H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Abbott H1N1 Vaccines Product
Table 53. Abbott Recent Developments/Updates
Table 54. Baxter International Corporation Information
Table 55. Baxter International Description and Business Overview
Table 56. Baxter International H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Baxter International H1N1 Vaccines Product
Table 58. Baxter International Recent Developments/Updates
Table 59. Sanofi Corporation Information
Table 60. Sanofi Description and Business Overview
Table 61. Sanofi H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Sanofi H1N1 Vaccines Product
Table 63. Sanofi Recent Developments/Updates
Table 64. GSK Corporation Information
Table 65. GSK Description and Business Overview
Table 66. GSK H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. GSK H1N1 Vaccines Product
Table 68. GSK Recent Developments/Updates
Table 69. Pfizer Corporation Information
Table 70. Pfizer Description and Business Overview
Table 71. Pfizer H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Pfizer H1N1 Vaccines Product
Table 73. Pfizer Recent Developments/Updates
Table 74. Mitsubishi Tanabe Pharma Corporation Information
Table 75. Mitsubishi Tanabe Pharma Description and Business Overview
Table 76. Mitsubishi Tanabe Pharma H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Mitsubishi Tanabe Pharma H1N1 Vaccines Product
Table 78. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 79. Hualan Biological Engineering Corporation Information
Table 80. Hualan Biological Engineering Description and Business Overview
Table 81. Hualan Biological Engineering H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Hualan Biological Engineering H1N1 Vaccines Product
Table 83. Hualan Biological Engineering Recent Developments/Updates
Table 84. Cipla Corporation Information
Table 85. Cipla Description and Business Overview
Table 86. Cipla H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Cipla H1N1 Vaccines Product
Table 88. Cipla Recent Developments/Updates
Table 89. Merck Corporation Information
Table 90. Merck Description and Business Overview
Table 91. Merck H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Merck H1N1 Vaccines Product
Table 93. Merck Recent Developments/Updates
Table 94. Sinovac Biotech Corporation Information
Table 95. Sinovac Biotech Description and Business Overview
Table 96. Sinovac Biotech H1N1 Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Sinovac Biotech H1N1 Vaccines Product
Table 98. Sinovac Biotech Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. H1N1 Vaccines Distributors List
Table 102. H1N1 Vaccines Customers List
Table 103. H1N1 Vaccines Market Trends
Table 104. H1N1 Vaccines Market Drivers
Table 105. H1N1 Vaccines Market Challenges
Table 106. H1N1 Vaccines Market Restraints
Table 107. Global H1N1 Vaccines Sales Forecast by Type (2023-2028) & (K Units)
Table 108. Global H1N1 Vaccines Sales Market Share Forecast by Type (2023-2028)
Table 109. Global H1N1 Vaccines Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 110. Global H1N1 Vaccines Revenue Market Share Forecast by Type (2023-2028)
Table 111. Global H1N1 Vaccines Sales Forecast by Application (2023-2028) & (K Units)
Table 112. Global H1N1 Vaccines Sales Market Share Forecast by Application (2023-2028)
Table 113. Global H1N1 Vaccines Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 114. Global H1N1 Vaccines Revenue Market Share Forecast by Application (2023-2028)
Table 115. Global H1N1 Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 116. Global H1N1 Vaccines Sales Market Share Forecast by Region (2023-2028)
Table 117. Global H1N1 Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 118. Global H1N1 Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of H1N1 Vaccines
Figure 2. Global H1N1 Vaccines Market Share by Type in 2021 & 2028
Figure 3. Intramuscular Vaccines Product Picture
Figure 4. Intranasal Vaccines Product Picture
Figure 5. Intradermal Vaccines Product Picture
Figure 6. Global H1N1 Vaccines Market Share by Application in 2021 & 2028
Figure 7. Influenza
Figure 8. Meningococcal
Figure 9. Cervical Cancer
Figure 10. Pneumococcal
Figure 11. Hepatitis
Figure 12. Measles
Figure 13. Mumps
Figure 14. Rubella
Figure 15. Others
Figure 16. Global H1N1 Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global H1N1 Vaccines Market Size (2017-2028) & (US$ Million)
Figure 18. Global H1N1 Vaccines Sales (2017-2028) & (K Units)
Figure 19. H1N1 Vaccines Sales Share by Manufacturers in 2021
Figure 20. Global H1N1 Vaccines Revenue Share by Manufacturers in 2021
Figure 21. The Global 5 and 10 Largest H1N1 Vaccines Players: Market Share by Revenue in 2021
Figure 22. H1N1 Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 23. Global H1N1 Vaccines Sales Market Share by Region (2017-2022)
Figure 24. Global H1N1 Vaccines Sales Market Share by Region in 2021
Figure 25. Global H1N1 Vaccines Revenue Market Share by Region (2017-2022)
Figure 26. Global H1N1 Vaccines Revenue Market Share by Region in 2021
Figure 27. U.S. H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Canada H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Germany H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. France H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. U.K. H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Italy H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Russia H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. China H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Japan H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. South Korea H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. India H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Australia H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Taiwan H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Indonesia H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Thailand H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Malaysia H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Philippines H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Vietnam H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. Mexico H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Brazil H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 47. Argentina H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 48. Turkey H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 49. Saudi Arabia H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 50. U.A.E H1N1 Vaccines Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 51. Sales Market Share of H1N1 Vaccines by Type (2017-2022)
Figure 52. Manufacturing Cost Structure of H1N1 Vaccines
Figure 53. Manufacturing Process Analysis of H1N1 Vaccines
Figure 54. H1N1 Vaccines Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

2023-2031 Report on Global Avian Influenza Vaccines Market by Player, Region, Type, Application and Sales Channel

Published: 18-Sep-2023        Price: US 2500 Onwards        Pages: 87

This report studies the Avian Influenza Vaccines market, covering market size for segment by type (Type H5, Type H9, etc.), by application (Chicken, Duck & Goose, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Merial, CEVA, Zoetis, Elanco (Lohmann), Merck Animal Health, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Avian Influenza ......

2023-2031 Report on Global Avian Influenza Vaccine Market by Player, Region, Type, Application and Sales Channel

Published: 04-Sep-2023        Price: US 2500 Onwards        Pages: 107

This report studies the Avian Influenza Vaccine market, covering market size for segment by type (H5+H7 Avian Influenza Vaccines, H9 Avian Influenza Vaccines, etc.), by application (Chicken, Duck & Goose, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Merial, QYH Biotech, DHN, HVRI, CEVA, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market f......

Global Pneumococcal Polysaccharide Vaccine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 22-Aug-2023        Price: US 3380 Onwards        Pages: 118

Market Overview of Global Pneumococcal Polysaccharide Vaccine market: According to our latest research, the global Pneumococcal Polysaccharide Vaccine market looks promising in the next 5 years. As of 2022, the global Pneumococcal Polysaccharide Vaccine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and com......

Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 03-Aug-2023        Price: US 3260 Onwards        Pages: 121

The 23-Valent Pneumococcal Polysaccharide Vaccine market revenue was 2268.96 Million USD in 2022, and will reach 3932.11 Million USD in 2028, with a CAGR of 9.6% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the 23-Valent Pneumococcal Polysaccharide Vaccine industry, and breaks down according to the type, application, and consumption area of 23-Valent Pneumococcal Polysaccharide Vaccine. The report also introduces players in......

Global Seasonal Influenza Vaccine Market (2023 Edition): Analysis By Vaccine Type (Inactivated, Live Attenuated), Valency (Quadrivalent, Trivalent), Age Group, Distribution Channel, By Region, By Country: Market Insights and Forecast (2019-2029)

Published: 01-Jul-2023        Price: US 2450 Onwards        Pages: 280

Executive Summary Azoth Analytics has released a research report titled "Global Seasonal Influenza Vaccine Market (2023 Edition)" which provides a complete analysis of the Global Seasonal Influenza Vaccine industry in terms of market segmentation By Vaccine Type (Inactivated Influenza Vaccine -IIV, Live Attenuated Influenza Vaccine - LAIV), Valency (Quadrivalent, Trivalent), Age Group (Pediatrics, Adults, Elderly) and By Distribution Channel (Hospitals, Pharmacies, Government Supp......

Global Japanese Encephalitis Vaccine Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 27-Jun-2023        Price: US 3260 Onwards        Pages: 97

The Japanese Encephalitis Vaccine market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Japanese Encephalitis Vaccine industry, and breaks down according to the type, application, and consumption area of Japanese Encephalitis Vaccine. The report also introduces players in the industry from the perspective of the industry chain an......

Global Meningococcal Conjugate Market Insights, Forecast to 2029

Published: 16-Jun-2023        Price: US 4900 Onwards        Pages: 114

Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meningococcal disease. Market Analysis and Insights: Global Meningococcal Conjugate Market The global Meningococcal Conjugate market is projected to grow from US$ million in 2023 to ......

Global Encephalitis Vaccination Market Insights: Impact of COVID-19 and Future Expectations to 2028

Published: 15-Jun-2023        Price: US 3260 Onwards        Pages: 118

The Encephalitis Vaccination market revenue was 52963.61 Million USD in 2022, and will reach 65320.29 Million USD in 2028, with a CAGR of 3.56% during 2022-2028. This report elaborates the market size, market characteristics, and market growth of the Encephalitis Vaccination industry, and breaks down according to the type, application, and consumption area of Encephalitis Vaccination. The report also introduces players in the industry from the perspective of the industry chain and......

Global Encephalitis Vaccine Market Insights, Forecast to 2029

Published: 31-May-2023        Price: US 4900 Onwards        Pages: 113

Encephalitis Vaccination is an effective measure for the prevention of epidemic encephalitis. It is by yellow virus arboviruses - je virus caused an acute infectious disease of the central nervous system. Often result in death or neurological sequel. Je is a zoonotic disease spread by mosquito's classes. People and many animals may be infection source after infection Encephalitis virus. The global Encephalitis Vaccine market is projected to grow from US$ 1374.4 million in 2023 to US$ 1905......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs